Fig. 33From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseDesigned structures as potential inhibitors of AChE and BuChE [50]Back to article page
